Table 2.

Clinical meta-analyses results

							Logistic
			NMSC					SCC					BCC
Clinical Variable	OR	Lower CI	Upper CI		Pbon	OR	Lower CI	Upper CI	Pun	Pbon	OR	Lower CI	Upper CI	Pun	Pbon
Age	1.02	1.016	2.56X10- 1.024 12		3.07X10- 11	1.02	1.01	1.03	3.27X10−13	3.92X10- 12	1.02	1.016	1.024	3.53X10−14	4.24X10- 13
Era	1.34	1.03	1.74 0.03		0.37	1.46	1.00	2.14	0.0521	0.63	1.50	0.89	2.51	0.1257	1
Sex	0.85	0.76	0.96 0.007		0.08	0.84	0.75	0.95	0.005	0.06	0.90	0.79	1.02	0.09	1
Azathioprine	1.13	0.95	1.34 0.18		1.00	1.11	0.93	1.32	0.24	1	1.11	0.91	1.34	0.32	1
							Cox
			NMSC					SCC					BCC
Clinical Variable	HR	Lower CI	Upper CI	Pun	Pbon	HR	Lower CI	Upper CI	Pun	Pbon	HR	Lower CI	Upper P CI un		Pbon
Age	1.06	1.04	1.08	3.35X10- 24	4.02X10- 23	1.07	1.05	1.09	3.85X10−18	4.62X10- 17	1.07	1.05	1.09 5.46X10−13		6.55X10- 12
Era	0.92	0.54	1.54	0.74	1.00	0.93	0.55	1.55	0.77	1	1.03	0.32	3.33 0.95		1
Sex	0.65	0.47	0.91	0.01	0.12	0.64	0.45	0.91	0.01	0.12	1.57	0.72	3.43 0.31		1
Azathioprine	2.23	1.04	4.78	0.04	0.48	3.06	0.84	11.17	0.09	1	0.76	0.44	1.32 0.33		1

NMSC=non-melanoma skin cancer, SCC = squamous cell carCInoma, BCC= basal cell carCInoma, OR = odds ratio, HR= hazards ratio, Lower/UpperCI = Lower/Upper 95% confidence interval, P_un=uncorrected p value, P_bon=Bonferroni corrected p value (corrected for 12 tests). Estimate for sex is assoCIated with females, OR/HR for age represents change in odds per year of age, era = those who had transplant pre-2000 = 1 and those who had transplant from 2000 onwards = 2